Akt-I-1,2

Cat. No.: OB0225WX-1645

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Akt-I-1,2 is a selective small molecule inhibitor designed to target the Akt1 and Akt2 isoforms of the protein kinase B family.

Synonym: 473382-50-2; Akt-I-1,2 HCl; AKT-IN-20; 2-[4-(3-Phenylquinoxalin-2-yl)phenyl]propan-2-amine; Hydrochloride; Benzenemethanamine, alpha,alpha-dimethyl-4-(3-phenyl-2-quinoxalinyl)-, monohydrochloride (9CI); 2-(4-(3-phenylquinoxalin-2-yl)phenyl)propan-2-amine hydrochloride; Benzenemethanamine, alpha,alpha-dimethyl-4-(3-phenyl-2-quinoxalinyl)-, hydrochloride (1:1); Akt-I-2 HCl; Benzenemethanamine, ,-dimethyl-4-(3-phenyl-2-quinoxalinyl)-, hydrochloride (1:1); Benzenemethanamine, ,-dimethyl-4-(3-phenyl-2-quinoxalinyl)-, monohydrochloride (9CI)

CAS No.: 473382-50-2

Compound CID: 73014064

Formula: C₂₃H₂₂ClN₃

Formula Weight: 375.89

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Akt-I-1,2 is employed in biochemical assays to specifically study the allosteric inhibition of the Akt1 and Akt2 isoforms and their distinct roles in cellular glucose transport.